.png){kind=icon}
返回
Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis
.png){kind=icon}
PRE
AI
DOI：10.1016/j.ijrobp.2018.03.001.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose: Salvage high-dose-rate brachytherapy (sHDRB) is a treatment option for recurrences after prior radiation therapy. However, only approximately 50% of patients benefit, with the majority of second recurrences after salvage brachytherapy occurring distantly. Therefore, identification of characteristics that can help select patients who may benefit most froms HDRB is critical. Machine learning may be used to identify characteristics that predict outcome following sHDRB. We aimed to use machine learning to identify patient characteristics associated with biochemical failure (BF) following prostate sHDRB. Methods and Materials: We analyzed data for 52 patients treated with sHDRB for locally recurrent prostate cancer after previous definitive radiation therapy between 1998 and 2009. Following pathologic confirmation of locally recurrent disease without evidence of metastatic disease, 36 Gy in 6 fractions was administered to the prostate and seminal vesicles. BF following sHDRB was defined using the Phoenix definition. Sixteen different clinical risk features were collected, and machine learning analysis was executed to identify subpopulations at higher risk of BF. Decision tree-based algorithms including classification and regression trees, MediBoost, and random forests were constructed. Results: Patients were followed up for a minimum of 5 years after sHDRB. Those with a fraction of positive cores >= 0.35 and a disease-free interval <4.12 years after their initial radiation treatment experienced a higher failure rate after sHDRB of 0.75 versus 0.38 for the rest of the population. Conclusions: Using machine learning, we have identified that patients with a fraction of positive cores >= 0.35 and a disease-free interval <4.1 years might be associated with a high risk of BF following sHDRB. (C) 2018 Elsevier Inc. All rights reserved.
Keyword:
RADIATION-THERAPY
PROSTATE-CANCER
DECISION-SUPPORT
TUMOR-CONTROL
RADIOTHERAPY
OUTCOMES
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
I
IF:
6.5
论文数:
4.8W
被引数:
4.2W
机构
引用论文
MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine.png)
SCIENTIFIC REPORTS
OAAI
SCIENTIFIC REPORTSIF3.9
OAAI分享收藏A mathematical framework for virtual IMRT QA using machine learning使用机器学习的虚拟IMRT QA数学框架MEDICAL PHYSICS
MEDICAL PHYSICSIF3.2
PREAI
分享收藏Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making放射治疗计划的临床决策支持: 用于患者特定剂量决策的数据驱动机器学习策略OAAI
OAAI分享收藏Regulation of fungal gene expression via short open reading frames in the mRNA 5′untranslated regionOAAI
OAAI分享收藏
查看更多内容